| Marzola, Michele (Meta Group 201509 + Non-executive Director at BIA Separitons doo) |
Investment Manager |
Meta Group (Group) |
|
| Ross, Alec (Amplo 202109 Board Partner + Visiting Prof at Univ Bologna Business School) |
Partner (venture partner) |
Amplo |
|
| Colinge, Jacques (Austrian Academi of Sciences 201202 Ce-M-M-Research Center for Molecular Medicine) |
Researcher (university / research institute) |
Austrian Academy of Sciences (ÖAW) |
Austria |
| Le Normand, Didier (Minoryx 201903– Group CFO + General Manager of Belgian subsidiary before Stat-Dx + Cellnovo) |
Chief Financial Officer (CFO) |
Minoryx (Group) |
Belgium |
| Manto, Michele (Galapagos 202001– promoted to CCO joined 201709 as SVP Commercial Operations before AbbVie |
Chief Commercial Officer (CCO) |
Galapagos (Group) |
Belgium |
| Liu, Jing (Akira) (Qianzhan Investment Management 201909 Biotech VC Investment Manager) |
Investment Manager |
Qianzhan Investment Management (QZ) |
China |
| Copestake, Andrew (Optimapharm 202007– CEO) |
Chief Executive Officer (CEO) |
Optimapharm (Group) |
Croatia |
| Dudfield, Phil (Galapagos 201301– Head of new Fidelta division before BioFocus DPI 200709 VP Discovery Products) |
President/Director/Head Business Group/Unit/Division |
Selvita (Group) |
Croatia |
| Greguric Cicak, Gordana (Otpimapharm 202007– COO before CEO + Founder since 2006) |
Chief Operating Officer (COO) |
Optimapharm (Group) |
Croatia |
| Helfgott, Ludovic (Novo Nordisk 202209 EVP + Head of Rare Disease formerly AstraZeneca 201506 President Spain) |
President/Director/Head of Research Organisation/Unit |
Novo Group (Group) |
Denmark |
| Naval, Jordi (InProTher 202102–Biocat 202003 CEO) |
Chief Executive Officer (CEO) |
InProTher ApS |
Denmark |
| Chiesi, Antonio (HansaBioMed Life Sciences OÜ 201705 Managing Director + Exosomics Siena SpA 201705 CEO) |
Managing Director |
Lonza (Group) |
Estonia |
| Camboni, Gabriella (Sofinnova Partners 202312 Partner before PinCell + BiovelocITA + EOS SpA + Novupharma) |
Partner (venture partner) |
Sofinnova (Group) |
France |
| Crespo, Laia (Sanofi 202109 EU Head of Investments at Sanofi Venture before Ysios Capital Partners) |
Investment Manager |
Sanofi (Group) [since May 2011] |
France |
| Faccio, Lucia (Sofinnova Partners 202004 Partner at Sofinnova Telethon Fund) |
Partner (venture partner) |
Sofinnova (Group) |
France |
| Pozzi, Paola (Sofinnova 202005 Partner at Sofinnova Partners) |
Partner (venture partner) |
Sofinnova (Group) |
France |
| de la Huerta Martinez, Pilar (Sygnis Pharma 201303– CEO + CFO before Genetrix CEO before Zeltia) |
Chief Executive Officer (CEO) |
2invest (Group) |
Germany |
| Guenter, Peter (Merck (DE) 202101– CEO Healthcare before Almirall + Sanofi + SmithKline + Ciba-Geigy) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Germany |
| Landwehr, Jörg (ActeaVentures 201403– Managing Partner before ActeaPartnering + PharmaMar + Roche) |
Managing Director |
ActeaVentures GmbH |
Germany |
| Peukert, Uwe (ActeaVentures 201403– Managing Partner before Roche + Lilly + Onyx + NewVac) |
Managing Director |
ActeaVentures GmbH |
Germany |
| Steyrer-Gruber, Silvia (Coriolis Pharma 202205– CEO before Exeltis/Insud Pharma + Baxter + Kwizda Pharma + Serono) |
Chief Executive Officer (CEO) |
Coriolis Pharma (Group) |
Germany |
| Aivaliotis, Michalis (FORTH 201202 IMBB-FORTH) |
n. a. |
FORTH (Foundation for Research and Technology – Hellas) |
Greece |
| Kountourakis, Nikos (FORTH 201202 Technician Proteomics Facility at IMBB-FORTH) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
FORTH (Foundation for Research and Technology – Hellas) |
Greece |
| Kritas, Stamatiki (Hellenic Biocluster 202305 Business Development Manager + CEBR 202305– Vice President) |
Cluster Manager |
Hellenic Biocluster (HBio) |
Greece |
| Pachnis, Vassilis (FORTH-IMBB 201202 Director) |
Researcher (university / research institute) |
FORTH (Foundation for Research and Technology – Hellas) |
Greece |
| Papanastasiou, Dimitrios (Fasmatech 2009– CSO + Co-Founder before Shimadzu Research Laboratory) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Fasmatech Science and Technology S.A. |
Greece |
| Raptakis, Emmanuel (Fasmatech 2009– CEO + Co-Founder before Shimadzu 200605 Product Manager at Shimadzu Biotech) |
Chief Executive Officer (CEO) |
Fasmatech Science and Technology S.A. |
Greece |
| Sakellaridis, Fotis (Theracell 202111 CEO) |
Chief Executive Officer (CEO) |
Theracell Advanced Biotechnology S.A. |
Greece |
| Admon, Arie (Technion 201008 Prof Dept of Biology + Head Smoler Proteomics Center) |
Professor |
Technion – Israel Institute of Technology |
Israel |
| Avinoam, Sapir (Teva 201608 VP + General Manager of Teva Israel) |
General Manager (management) |
Teva (Group) |
Israel |
| Ben-Asher, Dror (RedHill BioPharma 201406 CEO) |
Chief Executive Officer (CEO) |
RedHill Biopharma Ltd. (Nasdaq: RHDL) |
Israel |
| Ben-Yossef, Yossi (Kadimastem Ltd 201204 CEO) |
Chief Executive Officer (CEO) |
Kadimastem Ltd. |
Israel |
| Cohen-Dayag, Anat (Compugen 201112 CEO) |
Chief Executive Officer (CEO) |
Compugen (Group) |
Israel |
| Drucker, Miron (MegaPharm 201106 CEO + founder before Managing Director of Israel sub of Hoechst AG) |
Chief Executive Officer (CEO) |
MegaPharm Ltd. |
Israel |
| Falewich, Jacob (Affisink Biotechnology 201109 CEO) |
Chief Executive Officer (CEO) |
Affisink Biotechnology Ltd. |
Israel |
| Ferber, Sarah (Sheba Medical Center 201512 Professor) |
Professor |
Sheba Medical Center (Tel Hashomer, Ramat Gan) |
Israel |
| Fishman, Pnina (Can-Fite BioPharma 201312 CEO) |
Chief Executive Officer (CEO) |
Can-Fite (Group) |
Israel |
| Frydman, Lucio (Weizmann Institute 201308 Professor) |
Professor |
Weizmann Institute of Science |
Israel |
| Gavish, Michal (Israel Life Science Industry 201109 Office Manager) |
n. a. |
Israel Life Science Industry (ILSI) |
Israel |
| Granot-Mayer, Gil (Weizmann Institute 201405 Deputy CEO + General Counsel at Yeda RnD) |
IP Manager |
Weizmann Institute of Science |
Israel |
| Gross, Jonathan (BioData 201109 Co-CEO + founder) |
Chief Executive Officer (CEO) |
Holtzbrinck (Group) |
Israel |
| Haran, Gilad (Weizmann Institute 201604 Prof + Dean of Faculty of Chemistry) |
Professor |
Weizmann Institute of Science |
Israel |
| Haviv, Ofer (Evogene 200607 CEO) |
Chief Executive Officer (CEO) |
Evogene Ltd. (Nasdaq, TASE: EVGN) |
Israel |
| Kachalsky, Sylvia G. (Agazyme 200804– CEO) |
Regional manager |
Recipharm (Group) |
Israel |
| Kalif, Eli (Teva 201912– CFO before Flex Ltd) |
Chief Financial Officer (CFO) |
Teva (Group) |
Israel |
| Keren, Diva (Diva Keren 2004– Managing Director + Owner + Founder) |
Chief Executive Officer (CEO) |
Diva Keren Creative HR |
Israel |
| Levy-Lior, Avital (Weizmann Institute 201407 Senior Licensing Director at Yeda RnD) |
IP Manager |
Weizmann Institute of Science |
Israel |
| Mayer, Raphael (Raphy) (Affisink Biotechnology 200804– CTO) |
Chief Technology/Technical Officer (CTO) |
Affisink Biotechnology Ltd. |
Israel |
| Morik, Yosi (Arineta 201008 Chairman + co-founder) |
Board member |
Arineta Ltd. |
Israel |
| Navot, Nir (Pronto Diagnostics 201010 CEO) |
Chief Executive Officer (CEO) |
Pronto Diagnostics Ltd. |
Israel |
| Nussbaum, Ran (Pontifax 200712 Managing Partner also CEO of Biomedix Incubator) |
Managing Partner (investment firm) |
Pontifax (Group) |
Israel |
| Peimer, Issy (MegaPharm 201106 Business Development Manager before Novartis Israel + BMS Israel + MSD UK) |
Business Development Manager / Strategy Manager |
MegaPharm Ltd. |
Israel |
| Raz, Tamar (Hadassah 201510 CEO of Hadasit) |
Chief Executive Officer (CEO) |
Hadassah (HMO) (Group) |
Israel |
| Salhov, Aviv (Pronto Diagnostics 201010 VP Marketing + Operations) |
Sales Manager / Marketing Manager |
Pronto Diagnostics Ltd. |
Israel |
| Savitsky, Kinneret (FuturX 202012 CEO before BioLineRx 201001–201610 CEO joined 2004 before BioLine Innovations + CGEN) |
Chief Executive Officer (CEO) |
FutuRx Ltd. Biotechnology Incubator |
Israel |
| Schwebel, Alan (BioView 201306 CEO) |
Chief Executive Officer (CEO) |
BioView (Group) |
Israel |
| Shahar, Yair (Yair Technologies 201204) |
Chief Executive Officer (CEO) |
Yair Technologes (IL) |
Israel |
| Simhon, Shalom (Israel (govt) 201103 Minister of Industry, Trade and Labour) |
Minister |
Israel (govt) |
Israel |
| Stein, Alona (Blonde 2.0 201611 PR Supervisor) |
Public Relations Manager / Investor Relations Manager |
Blonde 2.0 (IL) |
Israel |
| Weisswasser, Sigal (T.B.N. Group 201201 President + Founder) |
President/Director/Head Business Group/Unit/Division |
T.B.N. Group (Technology Business Networks) (Group) |
Israel |
| Zisman, Einat (FutuRx 201705 CEO + Hadassah 201309 CEO of Hadasit) |
Chief Executive Officer (CEO) |
Hadassah (HMO) (Group) |
Israel |
| Ziv, Tamar (Technion 201008 Manager Smoler Proteomics Center) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
Technion – Israel Institute of Technology |
Israel |
| Ackermann, Niels (BioXell 200704– CFO before Morgan Stanley London + CFO of two German biotech companies) |
Chief Financial Officer (CFO) |
Cosmo Pharmaceuticals (Group) |
Italy |
| Aiolfi, Franco (Biohit 201304– CEO of Biohit Italy before EuroClone) |
Chief Executive Officer (CEO) |
Biohit (Group) |
Italy |
| Alberici, Luca (Asahi Glass 202403 General Manager + Managing Director at AGC Biologics Italy before MolMed 201903 CBO) |
Chief Business Officer (CBO) |
Asahi Glass (AGC) (Group) |
Italy |
| Aleotti, Alberto Giovanni (Menarini 201210 Board Member of A. Menarini) |
Board member |
Menarini (Group) |
Italy |
| Aleotti, Lucia (Menarini 201611 Group Chairman) |
Chief Executive Officer (CEO) |
Menarini (Group) |
Italy |
| Amabile, Giovanni (Enthera 202007 CEO) |
Chief Executive Officer (CEO) |
Enthera S.r.l. (Enthera Pharmaceuticals) |
Italy |
| Amadori, Giovanna (Chiesi Group 202011 Head of Global Strategy + Corporate Development) |
Business Development Manager / Strategy Manager |
Chiesi (Group) |
Italy |
| Amato, Antonino (Tony) (PinCell 202301– CEO) |
Chief Executive Officer (CEO) |
PinCell S.r.l. |
Italy |
| Anand, Ravi (Newron Pharmaceuticals 201103 CMO) |
Chief Medical Officer (CMO) |
Newron (Group) |
Italy |
| Ballerini, Andrea (Panakès Partners 202107–) |
n. a. |
Panakès Partners (Group) |
Italy |
| Banci, Lucia (Univ Florence 201908 Professor) |
Professor |
University of Florence |
Italy |
| Barcella, Michela (Panakès Partners 202310– Network + Portfolio Talent Manager before H-FARM College) |
Human Resources Manager |
Panakès Partners (Group) |
Italy |
| Barry Billings, Mark (Chiesi 201703 Head of Corporate Drug Development) |
President/Director/Head Business Group/Unit/Division |
Chiesi (Group) |
Italy |
| Beghé, Emenegildo (Naicons Srl 201804 Director Financial + Legal Affairs before Biosearch Italia) |
Chief Executive Officer (CEO) |
Naicons S.r.l. |
Italy |
| Benatti, Luca (EryDel 201804 CEO before Newron CEO + Founder) |
Chief Executive Officer (CEO) |
EryDel S.p.A. |
Italy |
| Berretta, Julia (Epsilen Bio 202006– CEO + Genespire 202004– CEO before Cellectis 2014–201812 VP BusDev) |
Chief Executive Officer (CEO) |
Genespire S.r.l. |
Italy |
| Beverina, Alessio (Panakés Partners 202107 Managing Partner + Co-Founder) |
Managing Partner (investment firm) |
Panakès Partners (Group) |
Italy |
| Binaschi, Monica (Menarini 201707) |
n. a. |
Menarini (Group) |
Italy |
| Biondi, Fabio (Diatech 201304 President of Diatech Pharmacogenetics Srl) |
Chief Executive Officer (CEO) |
Diatech (Group) |
Italy |
| Boffano, Paolo (Amplimedical 200604 CEO) |
Chief Executive Officer (CEO) |
Amplifon (Group) |
Italy |
| Bonfanti, Matteo (Istituto Italiano die Tecnologia 202203 Director of Technology Transfer) |
technology transfer |
Istituto Italiano di Tecnologia (IIT, Italian Institute of Technology) |
Italy |
| Boni, Alfredo (Creabilis 200806 President + Co-founder) |
President/Director/Head Business Group/Unit/Division |
Creabilis (Group) |
Italy |
| Boni, Renzo (Conserve Italia 201007 Lab Manager) |
Laboratory Manager (industry) |
Conserve Italia (Group) |
Italy |
| Boniolo, Antonio (former CEO of DiaSorin) |
Board member, non-executive |
Jointherapeutics S.r.l. |
Italy |
| Bordignon, Claudio (MolMed 200801 President + CEO) |
Chief Executive Officer (CEO) |
Asahi Glass (AGC) (Group) |
Italy |
| Bracco, Fulvio Renoldi (Bracco 201710 CEO at Bracco Imaging SpA) |
Chief Executive Officer (CEO) |
Bracco (Group) |
Italy |
| Braggio, Simone (Evotec 202210 EVP, Partnership Management Excellence + Board Member at EXTEND) |
Business Development Manager / Strategy Manager |
Italy (govt) |
Italy |
| Bucca, Valentina (Emmeplus 201404) |
n. a. |
Emmeplus S.r.l |
Italy |
| Buonaguidi, Marco (PerkinElmer 201407 Managing Director PerkinElmer Italy 201306 Turkey General Manager) |
Managing Director |
PerkinElmer (Group) |
Italy |
| Calabrese, Salvatore (MolMed 201809– CFO before Gentium CFO 2005–2014 + Novopharma SpA + PriceWaterhouseCoopers) |
Chief Financial Officer (CFO) |
Asahi Glass (AGC) (Group) |
Italy |
| Candotti, Ilaria (MolMed 201807 IR + Communication Manager) |
Public Relations Manager / Investor Relations Manager |
Asahi Glass (AGC) (Group) |
Italy |
| Cantore, Alessio (San Raffaele Hospital/Telethon) |
Professor |
San Raffaele of Monte Tabor Foundation |
Italy |
| Castellano, Barbara (Panakés Partners 202107 Partner) |
Partner (venture partner) |
Panakès Partners (Group) |
Italy |
| Castorina, Maurizio (Zambon 201511 CEO) |
Chief Executive Officer (CEO) |
Zambon (Group) |
Italy |
| Cattaneo, Antonino (Lay Line Genomics 200501 CEO) |
Chief Executive Officer (CEO) |
Lay Line Genomics S.p.A. (LLG) |
Italy |
| Cattaneo, Roberto (Bracco 201710 Media Relations at Bracco Imaging SpA) |
Public Relations Manager / Investor Relations Manager |
Bracco (Group) |
Italy |
| Centanaro, Sergio (Resnova 200609 Managing Director) |
Managing Director |
Resnova S.r.l. |
Italy |
| Chhabra, Meenu (BioXell 2003– 20061 promoted CBO) |
Chief Business Officer (CBO) |
Cosmo Pharmaceuticals (Group) |
Italy |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
